酒精使用障碍的管理:以胃肠病学和肝病学为重点的视角
Luis Antonio Díaz1, Daniel König2, Sabine Weber2
1Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA.
The lancet. Gastroenterology & hepatology
|February 16, 2025
概括
酒精使用障碍是全球主要的健康问题. 通过查工具及有效的非药物治疗方法进行早期诊断是治疗患者的关键,即使是肝病患者也是如此.
科学领域:
- 医学科学 医学科学 医学科学
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
背景情况:
- 酒精使用障碍 (AUD) 是全球发病率和死亡率的主要可预防的原因.
- AUD显著导致健康后果,特别是慢性肝病.
- 临床实践往往缺乏足够的酒精摄入量评估和AUD的综合管理.
研究的目的:
- 审查目前用于识别和管理酒精使用障碍的策略,特别是在肝病患者中.
- 突出标准化查工具和AUD有效干预措施的重要性.
- 强调需要多学科的护理在管理AUD与相关的肝脏疾病.
主要方法:
- 使用标准化问卷,如酒精使用识别测试 (AUDIT) 来识别风险.
- 使用酒精生物标志物,如酸乙醇,用于量化消费水平.
- 对AUD的非药理和药理干预措施的审查证据.
主要成果:
- 非药物干预对于AUD患者是有效的,无论肝病的阶段如何.
- 药物治疗需要考虑肝脏疾病的严重程度,并发症和安全性.
- 综合多学科团队管理是AUD肝病患者的理想选择.
结论:
- 对于酒精使用障碍存在有效的识别和管理策略.
- 查工具,非药物和量身定制的药物治疗的组合可以改善结果.
- 综合,多学科的护理对于患有AUD和相关肝病的患者至关重要.
相关概念视频
CNS Depressants: Alcohol and Nicotine
170
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
170
Peptic Ulcer Disease IV: Management
60
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
60
Esophageal Varices-II: Clinical Features and Management
36
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
36
Gastroesophageal Reflux Disease II: Clinical Features and Management
46
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
46
Chronic Pancreatitis II: Collaborative Care
58
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
58
Esophageal Varices-I: Introduction
64
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
64


